The term sarcopenia was introduced in 1988. The original definition was a “muscle loss” of
the appendicular muscle mass in the older people as measured by dual energy x‐ray …

Background Activities of daily living (ADLs) and instrumental activities of daily living (IADLs)
are essential for independent living and are predictors of morbidity and mortality in older …

The prevalence of obesity in combination with sarcopenia (the age-related loss of muscle
mass and strength or physical function) is increasing in adults aged 65 years and older. A …

Skeletal muscle is a major organ of insulin-induced glucose metabolism. In addition, loss of
muscle mass is closely linked to insulin resistance (IR) and metabolic syndrome (Met-S) …

Sarcopenia is defined as the age-related loss of muscle mass and strength or physical
performance. Increased amounts of adipose tissue often accompany sarcopenia, a condition …

Abstract The new ICD‐10‐CM (M62. 84) code for sarcopenia represents a major step
forward in recognizing sarcopenia as a disease. This should lead to an increase in …

Background Sarcopenic obesity is a clinical and functional condition characterized by the
coexistence of excess fat mass and sarcopenia. Currently, different definitions of sarcopenic …

The aging process is characterized by the chronic inflammatory status called
“inflammaging”, which shares major molecular and cellular features with the metabolism …

Excessive fat accumulation in the body may impair health leading to a significant long-term
health consequences including the development of diabetes, coronary heart disease, and …

The prevalence of overweight and obesity has reached epidemic proportions worldwide due
to increasingly pervasive obesogenic lifestyle changes. Obesity poses unprecedented …